Cancer & SURVIVEiT News
Category Filter:
FDA approves nivolumab for adjuvant treatment of urothelial carcinoma
FDA approves nivolumab for adjuvant treatment of urothelial carcinoma On August 19, 2021, the Food and Drug Administration approved nivolumab (Opdivo, Bristol-Myers Squibb Co.) for the adjuvant treatment of patients…
Bladder Cancer Patient Stories Plus Signs & Symptoms To Be Aware Of
May is bladder cancer awareness month, so we want to shed some light on this particular type of cancer. According to the World Bladder Cancer Patient Coalition, bladder cancer is…
FDA approves avelumab for urothelial carcinoma maintenance treatment
FDA approves avelumab for urothelial carcinoma maintenance treatment On June 30, 2020, the Food and Drug Administration approved avelumab (BAVENCIO,EMD Serono, Inc.) for maintenance treatment of patients with locally advanced…
Advocating For Yourself | Advice From A Bladder Cancer Survivor
A cancer diagnosis may leave you feeling many things, but one thing you shouldn’t feel is alone. Many people have felt the way you feel and have been through a…
FDA grants accelerated approval to erdafitinib for metastatic urothelial carcinoma
FDA grants accelerated approval to erdafitinib for metastatic urothelial carcinoma On April 12, 2019, the Food and Drug Administration granted accelerated approval to erdafitinib (BALVERSA, Janssen Pharmaceutical Companies) for patients…
Groundbreaking Results With Pembrolizumab Plus Surgery in Bladder Cancer
Groundbreaking Results With Pembrolizumab Plus Surgery in Bladder Cancer by Dave Levitan Nov 19, 2018 Neoadjuvant pembrolizumab was safe to administer and resulted in a significant proportion of patients with…